BRK-B vs HOPE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HOPE presents a complex profile with a stable Piotroski F-Score of 4/9 and significant valuation discounts, trading well below its Graham Number ($14.01) and Intrinsic Value ($14.46). While the company shows aggressive revenue (32%) and earnings growth (45.8%), these are offset by a critically unsustainable dividend payout ratio of 114.29%. The combination of bearish insider sentiment and low ROE (2.79%) suggests that while the asset is cheap on a book-value basis (P/B 0.69), internal health and capital allocation are concerning.
Compare Another Pair
Related Comparisons
BRK-B vs HOPE: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Hope Bancorp, Inc. (HOPE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.